LYSODREN Side Effects

6791048-0 | Alanine Aminotransferase Increased, Blood Cortisol Increased, Blood Sodium Decreased, Blood Thyroid Stimulating Hormone Decreased, Dehydroepiandrosterone Decreased, Disturbance In Attention, Dizziness, Eosinophil Count Increased
on Jun 14, 2010 Female patient from FRANCE , 73 years of age, was diagnosed with adrenocortical carcinoma, secondary adrenocortical insufficiency, pain (What is pain?) and was treated with Lysodren (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, blood cortisol increased, blood sodium decreased, blood thyroid stimulating hormone decreased, dehydroepiandrosterone decreased, disturbance in attention, dizziness (What is dizziness?), eosinophil count increased. Lysodren dosage: 6g/day. Interrupted On 20may10 And Restarted On 24may2010: 2df 2 In 1 D (2g/d) Duration:63 Days. During the same period patient was treated with HYDROCORTISONE (Hydrocortisone 10 Mg) (View Hydrocortisone Review and Hydrocortisone Label ), SIMVASTATIN (Simvastatin 10 Mg) (View Simvastatin Review and Simvastatin Label ), EFEROX (Efexor 125) (View Eferox Review and Eferox Label ), LISINOPRIL AND HYDROCHLOROTHIAZIDE (Lisiplus Al 20/12.5) (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), VIGANTOLETTEN (Vigantoletten 1000) (View Vigantoletten Review and Vigantoletten Label ), METOCLOPRAMIDE (1df 1 Unit Nos When Needed 3x20 Drp Metoclopramid Ratio Droplets) (View Metoclopramide Review and Metoclopramide Label ), DICLOFENAC (0.2857 Df (1 Df 2 In 1 Wk)) (View Diclofenac Review and Diclofenac Label ), OMEPRAZOLE (Omeprazole 20) (View Omeprazole Review and Omeprazole Label ).

6782623-8 | Asthenia, Decreased Appetite, Depression, Dysphagia, Weight Decreased
Patient was taking Lysodren (View Usage). Patient had the following side effects: asthenia, decreased appetite, depression (What is depression?), dysphagia, weight decreased on Jun 10, 2010 from FRANCE Additional patient health information: Female patient , 56 years of age, was diagnosed with adrenal carcinoma and. Lysodren dosage: . Patient was hospitalized and became disabled.

6779140-8 | Asthenia, Disturbance In Attention, Dysphemia, Memory Impairment, Somnolence, Vertigo
Adverse event was reported on Jun 09, 2010 by a Female patient taking Lysodren (View Usage) (Dosage: On Jan10 Dose Was 6.5g) was diagnosed with adrenocortical carcinoma and. Location: FRANCE , 47 years of age, After Lysodren was administered, patient had the following side effects: asthenia, disturbance in attention, dysphemia, memory impairment, somnolence, vertigo. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FLUDROCORTISONE (View Fludrocortisone Review and Fludrocortisone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ). Patient was hospitalized.

6599160-6 | Adrenal Insufficiency, Dehydration, Disturbance In Attention, Feeding Disorder, Personality Disorder, Self-induced Vomiting
on Feb 16, 2010 Female patient from FRANCE , 26 years of age, was diagnosed with adrenocortical carcinoma and was treated with Lysodren (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal insufficiency, dehydration, disturbance in attention, feeding disorder, personality disorder (What is personality disorder?), self-induced vomiting. Lysodren dosage: Initial Dose: 6tabs/d; Reduced To 4tabs/d. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FLORINEF (View Florinef Review and Florinef Label ). Patient was hospitalized.


6527208-3 | Abdominal Pain, Blood Alkaline Phosphatase Increased, Cytolytic Hepatitis, Gamma-glutamyltransferase Increased, Nausea, Rash
on Dec 28, 2009 Female patient from FRANCE , 37 years of age, was diagnosed with adrenocortical carcinoma, abdominal pain (What is abdominal pain?) and was treated with Lysodren (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), blood alkaline phosphatase increased, cytolytic hepatitis, gamma-glutamyltransferase increased, nausea (What is nausea?), rash (What is rash?). Lysodren dosage: 1df=1tab,16-20sep09,21-25sep,26-30sep,01-05oct09,06-11oct,12-18oct,20-25oct,25-26oct,27oct-02nov09.. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), CELESTENE (View Celestene Review and Celestene Label ), NUX VOMICA (View Nux Vomica Review and Nux Vomica Label ).

6497509-6 | Diarrhoea, Weight Decreased
Patient was taking Lysodren (View Usage). After Lysodren was administered, patient had the following side effects: diarrhoea, weight decreased on Dec 03, 2009 from FRANCE Additional patient health information: Male patient , 64 years of age, . Lysodren dosage: . During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

6483753-0 | Cytolytic Hepatitis, Rash
Adverse event was reported on Nov 26, 2009 by a Female patient taking Lysodren (View Usage) (Dosage: ) was diagnosed with adrenocortical carcinoma and. Location: FRANCE , 37 years of age, Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, rash (What is rash?).

6397505-3 | Liver Function Test Abnormal
on Oct 01, 2009 Female patient from FRANCE , 29 years of age, weighting 163.1 lb, was diagnosed with adrenal carcinoma and was treated with Lysodren (View Usage). Patient had the following side effects: liver function test abnormal. Lysodren dosage: . During the same period patient was treated with CRESTOR (1 Df= 40(unit Not Spec)) (View Crestor Review and Crestor Label ), EZETROL (1 Df= 10(unit Not Spec)) (View Ezetrol Review and Ezetrol Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FLUDROCORTISONE (View Fludrocortisone Review and Fludrocortisone Label ).

6329643-5 | Dyslipidaemia, Gamma-glutamyltransferase Increased
on Aug 18, 2009 Male patient from FRANCE , 68 years of age, was diagnosed with adrenocortical carcinoma, blood corticotrophin abnormal and was treated with Lysodren (View Usage). After Lysodren was administered, patient had the following side effects: dyslipidaemia, gamma-glutamyltransferase increased. Lysodren dosage: . During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), ZANIDIP (View Zanidip Review and Zanidip Label ).

6263196-5 | Hepatitis Toxic, Malignant Neoplasm Progression
Patient was taking Lysodren (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis toxic, malignant neoplasm progression on Jun 29, 2009 from FRANCE Additional patient health information: Female patient , 30 years of age, was diagnosed with adrenocortical carcinoma, hyperadrenocorticism, nausea (What is nausea?) and. Lysodren dosage: Started On 01dec07: 3 Tabs/d:1.5g/d From 6may09-15tabs/d(7.5g/d). During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), ADRIAMYCIN RDF (View Adriamycin Rdf Review and Adriamycin Rdf Label ), ZANOSAR (Had Received Four Cycles) (View Zanosar Review and Zanosar Label ), NIZORAL (1 Df = 200 (units Not Provided)-1tabs/d Increased Gradually To 800mg/d) (View Nizoral Review and Nizoral Label ), PRIMPERAN (Primperan Iv) (View Primperan Review and Primperan Label ), LOXEN LP (Loxen Lp 50) (View Loxen Lp Review and Loxen Lp Label ), HYDROCORTISONE (Hydrocortisone 10) (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

6211113-6 | Adrenal Insufficiency, Apathy, Hypokinesia, Meningism
Adverse event was reported on May 25, 2009 by a Female patient taking Lysodren (View Usage) (Dosage: ) was diagnosed with adrenocortical carcinoma and. Location: FRANCE , 65 years of age, Patient had the following side effects: adrenal insufficiency, apathy, hypokinesia, meningism. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), DIFFU K (View Diffu-k Review and Diffu-k Label ), SOTALOL HYDROCHLORIDE (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ), ORACILLINE (View Oracilline Review and Oracilline Label ), DECTANCYL (View Dectancyl Review and Dectancyl Label ), AMLOR (View Amlor Review and Amlor Label ), TAHOR (Tahor 10) (View Tahor Review and Tahor Label ). Patient was hospitalized.

6169582-6 | Anorexia, Arthralgia, Asthenia, Balance Disorder, Depression, Diarrhoea, Dizziness, Feeling Drunk, Folate Deficiency
on Apr 20, 2009 Female patient from FRANCE , 53 years of age, was diagnosed with adrenocortical carcinoma and was treated with Lysodren (View Usage). After Lysodren was administered, patient had the following side effects: anorexia, arthralgia, asthenia, balance disorder, depression (What is depression?), diarrhoea, dizziness (What is dizziness?), feeling drunk, folate deficiency. Lysodren dosage: . During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

6141055-6 | Anorexia, Nausea, Weight Decreased
on Mar 23, 2009 Female patient from FRANCE , 49 years of age, was diagnosed with adrenocortical carcinoma and was treated with Lysodren (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, nausea (What is nausea?), weight decreased. Lysodren dosage: . During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

6107274-X | Abasia, Adrenal Insufficiency, Fatigue, Loss Of Consciousness, Malaise
Patient was taking Lysodren (View Usage). Patient had the following side effects: abasia, adrenal insufficiency, fatigue, loss of consciousness, malaise on Mar 04, 2009 from FRANCE Additional patient health information: Male patient , 43 years of age, was diagnosed with adrenocortical carcinoma and. Lysodren dosage: 1 Dosage Form= 6-9 Tabs. During the same period patient was treated with HYDROCORTISONE (1 Dosage Form= 5-6 Units Not Specified.) (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

6105190-0 | Optic Neuritis, Scotoma, Vision Blurred, Visual Acuity Reduced
Adverse event was reported on Feb 24, 2009 by a Male patient taking Lysodren (View Usage) (Dosage: Already Taken From 24aug07-07sep + From 1oct-22oct07 Restarted On 28jul08 1 Dosage Form = 6 Tabs.) was diagnosed with adrenocortical carcinoma and. Location: FRANCE , 29 years of age, After Lysodren was administered, patient had the following side effects: optic neuritis, scotoma, vision blurred, visual acuity reduced. Patient was hospitalized.

6094173-5 | Neutropenia, Pyrexia
on Feb 05, 2009 Female patient from FRANCE , 40 years of age, was diagnosed with adrenocortical carcinoma, osteoporosis prophylaxis, gastritis, rash (What is rash?), hypothyroidism, urinary tract infection (What is urinary tract infection?) and was treated with Lysodren (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia, pyrexia. Lysodren dosage: 3g/day: 09-jan-2009 To 26-jan-2009: 17 Days: Orally.. During the same period patient was treated with IDEOS (View Ideos Review and Ideos Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), DECORTIN (View Decortin Review and Decortin Label ), FENISTIL (View Fenistil Review and Fenistil Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ). Patient was hospitalized.

6091259-6 | Cerebellar Ataxia, Encephalopathy, Hypogonadism
on Feb 16, 2009 Male patient from FRANCE , 61 years of age, was diagnosed with adrenocortical carcinoma, hypothyroidism and was treated with Lysodren (View Usage). Patient had the following side effects: cerebellar ataxia, encephalopathy, hypogonadism. Lysodren dosage: Increased Rapidly To 5gm Daily. During the same period patient was treated with THYROXINE (View Thyroxine Review and Thyroxine Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), PROBIOTICA (View Probiotica Review and Probiotica Label ).

6088685-8 | Thrombocytopenia
Patient was taking Lysodren (View Usage). After Lysodren was administered, patient had the following side effects: thrombocytopenia on Feb 11, 2009 from FRANCE Additional patient health information: Female patient , 43 years of age, was diagnosed with adrenocortical carcinoma and. Lysodren dosage: . During the same period patient was treated with CISPLATYL (View Cisplatyl Review and Cisplatyl Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VEPESID (View Vepesid Review and Vepesid Label ). Patient was hospitalized.

6070930-6 | Confusional State, Dehydration, Diarrhoea, Hypokalaemia, Hyponatraemia, Vomiting
Adverse event was reported on Jan 26, 2009 by a Male patient taking Lysodren (View Usage) (Dosage: ) was diagnosed with adrenocortical carcinoma and. Location: FRANCE , 45 years of age, Patient experienced the following unwanted or unexpected effects: confusional state, dehydration, diarrhoea, hypokalaemia, hyponatraemia, vomiting. During the same period patient was treated with CISPLATYL (View Cisplatyl Review and Cisplatyl Label ), VEPESID (View Vepesid Review and Vepesid Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ). Patient was hospitalized.

6053987-8 | Asthenia, Performance Status Decreased, Somnolence
on Jan 19, 2009 Female patient from FRANCE , 49 years of age, was diagnosed with adrenocortical carcinoma and was treated with Lysodren (View Usage). Patient had the following side effects: asthenia, performance status decreased, somnolence. Lysodren dosage: 5g/day Till 22-oct-2008 Reintroduced On 31oct08 At 2g/day.. During the same period patient was treated with ASTONIN H (View Astonin-h Review and Astonin-h Label ). Patient was hospitalized.

6045473-6 | Anaemia, Aplasia Pure Red Cell, Neutropenia, Thrombocythaemia
on Jan 09, 2009 Female patient from FRANCE , 59 years of age, was diagnosed with adrenocortical carcinoma, secondary adrenocortical insufficiency, insomnia and was treated with Lysodren (View Usage). After Lysodren was administered, patient had the following side effects: anaemia, aplasia pure red cell, neutropenia, thrombocythaemia. Lysodren dosage: 3g/d 10aug08; 4.5g/d 11,12aug08; 2g/d 13aug-09sep08; 3g/d Until 14oct08.. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), STILNOX (View Stilnox Review and Stilnox Label ). Patient was hospitalized.

5965582-7 | Anorexia, Dysarthria, Fatigue, Lethargy, Memory Impairment
Patient was taking Lysodren (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, dysarthria, fatigue, lethargy, memory impairment on Nov 18, 2008 from FRANCE Additional patient health information: Male patient , 52 years of age, was diagnosed with recurrent cancer, adrenal carcinoma, adrenal insufficiency and. Lysodren dosage: . During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FLUDROCORTISONE ACETATE (View Fludrocortisone Acetate Review and Fludrocortisone Acetate Label ).

5965572-4 | Anaemia, Aplasia Pure Red Cell, Neutropenia, Thrombocythaemia
Adverse event was reported on Nov 17, 2008 by a Female patient taking Lysodren (View Usage) (Dosage: 3g/d 10aug08; 4.5g/d 11,12aug08; 3g/d Until 14oct08) was diagnosed with adrenocortical carcinoma, secondary adrenocortical insufficiency, insomnia and. Location: FRANCE , 59 years of age, Patient had the following side effects: anaemia, aplasia pure red cell, neutropenia, thrombocythaemia. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

5959278-5 | Asthenia, Performance Status Decreased, Somnolence
on Nov 12, 2008 Female patient from FRANCE , 49 years of age, was diagnosed with adrenocortical carcinoma and was treated with Lysodren (View Usage). After Lysodren was administered, patient had the following side effects: asthenia, performance status decreased, somnolence. Lysodren dosage: Reintroduced On 31oct08 At 2g/day.. Patient was hospitalized.

5954184-4 | Anaemia, Aplasia Pure Red Cell
on Nov 06, 2008 Female patient from FRANCE , 59 years of age, was diagnosed with adrenocortical carcinoma, secondary adrenocortical insufficiency, insomnia and was treated with Lysodren (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, aplasia pure red cell. Lysodren dosage: 3g/d 10aug08; 4.5g/d 11,12aug08; 3g/d Until 14oct08. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

5952851-X | Hepatic Enzyme Increased, Malignant Neoplasm Progression, Pulmonary Embolism
Patient was taking Lysodren (View Usage). Patient had the following side effects: hepatic enzyme increased, malignant neoplasm progression, pulmonary embolism (What is pulmonary embolism?) on Nov 07, 2008 from FRANCE Additional patient health information: Female patient , 58 years of age, was diagnosed with adrenocortical carcinoma, hypothyroidism, hypertension, hypercorticoidism and. Lysodren dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), BELOC ZOK (View Beloc-zok Review and Beloc-zok Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), TOREM (View Torem Review and Torem Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), ESIDRIX (View Esidrix Review and Esidrix Label ), METOPIRONE (View Metopirone Review and Metopirone Label ). Patient was hospitalized.

5942890-7 | Asthenia, Diarrhoea, Dizziness, Malignant Neoplasm Progression, Nausea, Somnolence
Adverse event was reported on Oct 30, 2008 by a Female patient taking Lysodren (View Usage) (Dosage: 21dec07-16jul08: 4gm 17jul08 To Unk: 2gm Unk To 12aug08: 1.5gm) was diagnosed with adrenal carcinoma and. Location: FRANCE , 57 years of age, After Lysodren was administered, patient had the following side effects: asthenia, diarrhoea, dizziness (What is dizziness?), malignant neoplasm progression, nausea (What is nausea?), somnolence. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

5938369-9 | Asthenia, Diarrhoea, Dizziness, Malignant Neoplasm Progression, Nausea, Somnolence
on Oct 22, 2008 Female patient from FRANCE , 57 years of age, was diagnosed with adrenal carcinoma and was treated with Lysodren (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, diarrhoea, dizziness (What is dizziness?), malignant neoplasm progression, nausea (What is nausea?), somnolence. Lysodren dosage: 21dec07-16jul08: 4gm 17jul08 To Unk: 2gm Unk To 12aug08: 1.5gm. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

5934953-7 | Anaemia, Aplasia Pure Red Cell
on Oct 14, 2008 Female patient from FRANCE , 59 years of age, was diagnosed with adrenocortical carcinoma, secondary adrenocortical insufficiency, insomnia and was treated with Lysodren (View Usage). Patient had the following side effects: anaemia, aplasia pure red cell. Lysodren dosage: 3g/d 10aug08; 4.5g/d 11,12aug08; 3g/d Until 14oct08. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

5925285-1 | Anaemia, Aplasia Pure Red Cell
Patient was taking Lysodren (View Usage). After Lysodren was administered, patient had the following side effects: anaemia, aplasia pure red cell on Oct 14, 2008 from FRANCE Additional patient health information: Female patient , 59 years of age, was diagnosed with adrenocortical carcinoma, secondary adrenocortical insufficiency, insomnia and. Lysodren dosage: 6dosage Form = 6 Tabs;(09aug08)3tabs/d;(10aug08)6tabs/d;(11,12aug08)9tabs/d.discontd On 14oct08.. During the same period patient was treated with HYDROCORTISONE 10MG TAB (View Hydrocortisone 10mg Tab Review and Hydrocortisone 10mg Tab Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

5909834-5 | Abnormal Dreams, Amnesia, Asthenia, Disturbance In Attention, Dyspnoea, Exercise Tolerance Decreased, Hypogonadism, Hypotrichosis, Loss Of Libido
Adverse event was reported on Sep 25, 2008 by a Male patient taking Lysodren (View Usage) (Dosage: Started As 5g/d Reduced To 3g/d And Reduced To 2g/d.) was diagnosed with adrenal carcinoma and. Location: FRANCE , 60 years of age, Patient experienced the following unwanted or unexpected effects: abnormal dreams, amnesia, asthenia, disturbance in attention, dyspnoea, exercise tolerance decreased, hypogonadism, hypotrichosis, loss of libido.

5909818-7 | Adrenal Insufficiency, Fatigue, Hypothyroidism, Memory Impairment, Neutrophil Count Decreased, Rash, Red Blood Cell Count Decreased, Somnolence, White Blood Cell Count Decreased
on Sep 25, 2008 Male patient from FRANCE , 60 years of age, was diagnosed with adrenal carcinoma and was treated with Lysodren (View Usage). Patient had the following side effects: adrenal insufficiency, fatigue, hypothyroidism, memory impairment, neutrophil count decreased, rash (What is rash?), red blood cell count decreased, somnolence, white blood cell count decreased. Lysodren dosage: 06aug08,5g/day. Reduced To 2g/day.on 12aug08 Daily Dose Was 5g/day, On 26aug08 Was 5g/day.. During the same period patient was treated with LEVOTHYROXINE SODIUM (Increased To 100mcg/day.) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

5863942-6 | Adrenal Insufficiency, Fatigue, Hypothyroidism, Memory Impairment, Neutrophil Count Decreased, Rash, Red Blood Cell Count Decreased, Somnolence, White Blood Cell Count Decreased
on Aug 21, 2008 Male patient from FRANCE , 60 years of age, was diagnosed with adrenal carcinoma and was treated with Lysodren (View Usage). After Lysodren was administered, patient had the following side effects: adrenal insufficiency, fatigue, hypothyroidism, memory impairment, neutrophil count decreased, rash (What is rash?), red blood cell count decreased, somnolence, white blood cell count decreased. Lysodren dosage: 06aug08,5g/day.. During the same period patient was treated with THYROXINE (Increased To 100mcg/day.) (View Thyroxine Review and Thyroxine Label ).

5836263-5 | Hypothyroidism, Neutrophil Count Decreased, Rash, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
Patient was taking Lysodren (View Usage). Patient experienced the following unwanted or unexpected effects: hypothyroidism, neutrophil count decreased, rash (What is rash?), red blood cell count decreased, white blood cell count decreased on Jul 30, 2008 from FRANCE Additional patient health information: Male patient , 60 years of age, was diagnosed with adrenal carcinoma and. Lysodren dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (Increased To 100mcg/day.) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

5834073-6 | Proteinuria
Adverse event was reported on Jul 30, 2008 by a Male patient taking Lysodren (View Usage) (Dosage: ) was diagnosed with adrenocortical carcinoma and. Location: FRANCE , 47 years of age, Patient had the following side effects: proteinuria. During the same period patient was treated with STREPTOZOCIN (View Streptozocin Review and Streptozocin Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ). Patient was hospitalized.

5833223-5 | Anaemia, Chills, Epistaxis, Febrile Neutropenia, Hyperthermia, Thrombocytopenia
on Jul 30, 2008 Male patient from FRANCE , 66 years of age, was diagnosed with adrenocortical carcinoma and was treated with Lysodren (View Usage). After Lysodren was administered, patient had the following side effects: anaemia, chills, epistaxis, febrile neutropenia, hyperthermia, thrombocytopenia. Lysodren dosage: . During the same period patient was treated with VEPESID (View Vepesid Review and Vepesid Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CISPLATYL (View Cisplatyl Review and Cisplatyl Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FLUDROCORTISONE ACETATE (View Fludrocortisone Acetate Review and Fludrocortisone Acetate Label ), XYZAL (View Xyzal Review and Xyzal Label ), NEXIUM (View Nexium Review and Nexium Label ), NOVOLOG MIX 70/30 (View Novolog Mix 70/30 Review and Novolog Mix 70/30 Label ). Patient was hospitalized.

5828595-1 | Hepatic Enzyme Increased, Malignant Neoplasm Progression, Pulmonary Embolism
on Jul 23, 2008 Female patient from FRANCE , 58 years of age, was diagnosed with adrenocortical carcinoma, hypothyroidism, hypertension, hypercorticoidism and was treated with Lysodren (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, malignant neoplasm progression, pulmonary embolism (What is pulmonary embolism?). Lysodren dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), BELOC ZOK (View Beloc-zok Review and Beloc-zok Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), TOREM (View Torem Review and Torem Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), ESIDRIX (View Esidrix Review and Esidrix Label ), METOPIRONE (View Metopirone Review and Metopirone Label ). Patient was hospitalized.

5827398-1 | Hypothyroidism, Neutrophil Count Decreased, Rash, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
Patient was taking Lysodren (View Usage). Patient had the following side effects: hypothyroidism, neutrophil count decreased, rash (What is rash?), red blood cell count decreased, white blood cell count decreased on Jul 21, 2008 from FRANCE Additional patient health information: Male patient , 60 years of age, was diagnosed with adrenal carcinoma and. Lysodren dosage: .

5821709-9 | Hypothyroidism, Neutrophil Count Decreased, Rash, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Jul 21, 2008 by a Male patient taking Lysodren (View Usage) (Dosage: ) was diagnosed with adrenal carcinoma and. Location: FRANCE , 60 years of age, After Lysodren was administered, patient had the following side effects: hypothyroidism, neutrophil count decreased, rash (What is rash?), red blood cell count decreased, white blood cell count decreased.

5796128-4 | Depressed Level Of Consciousness, Overdose, Respiratory Distress
on Jun 23, 2008 Male patient from FRANCE , 55 years of age, was treated with Lysodren (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, overdose, respiratory distress. Lysodren dosage: Daily Dose Was 1.5 Gram.. Patient was hospitalized.

5793608-2 | Hepatitis Toxic
on Jun 13, 2008 Male patient from DENMARK , 47 years of age, was diagnosed with adrenal carcinoma and was treated with Lysodren (View Usage). Patient had the following side effects: hepatitis toxic. Lysodren dosage: Dose Was Reduced To 4 G Daily..

5774723-6 | Depressed Level Of Consciousness, Overdose, Respiratory Distress
Patient was taking Lysodren (View Usage). After Lysodren was administered, patient had the following side effects: depressed level of consciousness, overdose, respiratory distress on Jun 09, 2008 from FRANCE Additional patient health information: Male patient , 55 years of age, . Lysodren dosage: . Patient was hospitalized.

5752245-6 | Hepatic Enzyme Increased
Adverse event was reported on May 22, 2008 by a Male patient taking Lysodren (View Usage) (Dosage: Dose Was Reduced To 4 G Daily.) was diagnosed with adrenal carcinoma and. Location: FRANCE , 47 years of age, Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased.

5748972-7 | Hypokalaemia, Malignant Neoplasm Progression, Psychomotor Hyperactivity, Sleep Disorder
on May 20, 2008 Female patient from FRANCE , 70 years of age, was diagnosed with adrenocortical carcinoma and was treated with Lysodren (View Usage). Patient had the following side effects: hypokalaemia, malignant neoplasm progression, psychomotor hyperactivity, sleep disorder (What is sleep disorder?). Lysodren dosage: 1 Dosage Form=between 3 And 12 Tablets. During the same period patient was treated with LISINOPRIL (Lisinopril 20 Mg) (View Lisinopril Review and Lisinopril Label ), FURO (View Furo Review and Furo Label ). Patient was hospitalized.

5746257-6 | Hypokalaemia, Neoplasm Progression, Psychomotor Hyperactivity, Sleep Disorder
on May 20, 2008 Female patient from GERMANY , 70 years of age, was diagnosed with adrenocortical carcinoma and was treated with Lysodren (View Usage). After Lysodren was administered, patient had the following side effects: hypokalaemia, neoplasm progression, psychomotor hyperactivity, sleep disorder (What is sleep disorder?). Lysodren dosage: 1 Dosageform = Between 3 To 12 Tablets. During the same period patient was treated with PRINIVIL (Strength 20mg. 1 Dosageform = 0.5 Dosageform) (View Prinivil Review and Prinivil Label ), FURO (Furo Ct 40) (View Furo Review and Furo Label ). Patient was hospitalized.

5726725-3 | Depressed Level Of Consciousness, Overdose, Respiratory Distress
Patient was taking Lysodren (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, overdose, respiratory distress on Apr 22, 2008 from FRANCE Additional patient health information: Male patient , 55 years of age, . Lysodren dosage: . Patient was hospitalized.

5712998-X | Abdominal Pain, Adrenal Insufficiency, Alanine Aminotransferase Abnormal, Anorexia, Blood Count Abnormal, Blood Glucose Increased, Blood Potassium Decreased, Dizziness, Epigastric Discomfort
Adverse event was reported on Apr 09, 2008 by a Female patient taking Lysodren (View Usage) (Dosage: 6g/d-20aug07-12feb08.discontinued-12feb08-7mar08.7mar08-4500mg/d.18mar08-reduced To 3000mg/d.) was diagnosed with adrenocortical carcinoma and. Location: FRANCE , 54 years of age, weighting 149.9 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), adrenal insufficiency, alanine aminotransferase abnormal, anorexia, blood count abnormal, blood glucose increased, blood potassium decreased, dizziness (What is dizziness?), epigastric discomfort. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FLUDROCORTISONE ACETATE (1 Dosage Form=50(units Not Specified)) (View Fludrocortisone Acetate Review and Fludrocortisone Acetate Label ). Patient was hospitalized.

5689202-4 | Anorexia, Blood Count Abnormal, Blood Potassium Decreased, Fatigue, Liver Function Test Abnormal, Myalgia, Nausea, Skin Irritation
on Mar 21, 2008 Female patient from FRANCE , 54 years of age, weighting 149.9 lb, was diagnosed with adrenocortical carcinoma and was treated with Lysodren (View Usage). After Lysodren was administered, patient had the following side effects: anorexia, blood count abnormal, blood potassium decreased, fatigue, liver function test abnormal, myalgia, nausea (What is nausea?), skin irritation. Lysodren dosage: . During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FLUDROCORTISONE ACETATE (View Fludrocortisone Acetate Review and Fludrocortisone Acetate Label ). Patient was hospitalized.

5651086-8 | Anaemia, Chills, Epistaxis, Febrile Neutropenia, Hyperthermia, Thrombocytopenia
on Feb 22, 2008 Male patient from FRANCE , 66 years of age, was diagnosed with adrenocortical carcinoma and was treated with Lysodren (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, chills, epistaxis, febrile neutropenia, hyperthermia, thrombocytopenia. Lysodren dosage: . During the same period patient was treated with VEPESID (View Vepesid Review and Vepesid Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CISPLATYL (View Cisplatyl Review and Cisplatyl Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FLUDROCORTISONE ACETATE (View Fludrocortisone Acetate Review and Fludrocortisone Acetate Label ), XYZAL (View Xyzal Review and Xyzal Label ), NEXIUM (View Nexium Review and Nexium Label ), NOVOLOG MIX 70/30 (View Novolog Mix 70/30 Review and Novolog Mix 70/30 Label ). Patient was hospitalized.

5620440-2 |
Patient was taking Lysodren (View Usage). on Jan 24, 2008 from FRANCE Additional patient health information: Male patient , 63 years of age, . Lysodren dosage: .